Human Immunodeficiency Virus Type 1 Tat Regulates Endothelial Cell Actin Cytoskeletal Dynamics through PAK1 Activation and Oxidant Production

ABSTRACT Human immunodeficiency virus type 1 Tat exerts prominent angiogenic effects which may lead to a variety of vasculopathic conditions in AIDS patients. Because endothelial cells undergo prominent cytoskeletal rearrangement during angiogenesis, we investigated the specific effects of Tat on the endothelial cell actin cytoskeleton. Glutathione S-transferase (GST)-Tat, at a level of 200 ng/ml (equivalent to 52 ng of Tat/ml), caused stress fiber disassembly, peripheral retraction, and ruffle formation in human umbilical vein endothelial cells (HUVEC) and human lung microvascular endothelial cells. At 600 ng of GST-Tat/ml (157 ng of Tat/ml), actin structures were lost, and severe cytoskeletal collapse occurred. In contrast, GST-Tat harboring mutations within either the cysteine-rich or basic domains exerted minimal effects on the endothelial cytoskeleton. HUVEC expressing a DsRed-Tat fusion protein displayed similar actin rearrangements, followed by actin collapse, whereas neighboring nontransfected cells retained normal actin structures. Because active mutants of p21-activated kinase 1 (PAK1) induce identical changes in actin dynamics, we hypothesized that Tat exerts its cytoskeletal effects through PAK1. GST-Tat activated PAK1 within 5 min, and adenovirus delivery of a kinase-dead PAK1 [PAK1(K298A)] completely prevented cytoskeletal collapse induced by GST-Tat or DsRed-Tat and also blocked downstream activation of c-Jun N-terminal kinase. Further, GST-Tat increased phosphorylation of the NADPH oxidase subunit p47phox and caused its rapid redistribution to membrane ruffles. PAK1(K298A) blocked p47phox phosphorylation, and interference with NADPH oxidase function through superoxide scavenging or through expression of a transdominant inhibitor, p67(V204A), prevented GST-Tat-induced alterations in the actin cytoskeleton. We conclude that Tat induces actin cytoskeletal rearrangements through PAK1 and downstream activation of the endothelial NADPH oxidase.

[1]  F. Nwariaku,et al.  p47 phox Participates in Activation of RelA in Endothelial Cells* , 2003, The Journal of Biological Chemistry.

[2]  F. Nwariaku,et al.  Involvement of TRAF4 in Oxidative Activation of c-Jun N-terminal Kinase* , 2002, The Journal of Biological Chemistry.

[3]  M. Gerritsen,et al.  A Dominant-Negative p65 PAK Peptide Inhibits Angiogenesis , 2002, Circulation research.

[4]  R. Kerbel,et al.  Dok‐R plays a pivotal role in angiopoietin‐1‐dependent cell migration through recruitment and activation of Pak , 2001, The EMBO journal.

[5]  Y. Gu,et al.  HIV Tat activates c-Jun amino-terminal kinase through an oxidant-dependent mechanism. , 2001, Virology.

[6]  R. Jaussi,et al.  Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity. , 2001, The Biochemical journal.

[7]  S. Schmid,et al.  Regulation of macropinocytosis by p21-activated kinase-1. , 2000, Molecular biology of the cell.

[8]  M. Mandal,et al.  Regulation of Microfilament Reorganization and Invasiveness of Breast Cancer Cells by Kinase Dead p21-activated Kinase-1* , 2000, The Journal of Biological Chemistry.

[9]  T. Joh,et al.  HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways , 2000, AIDS.

[10]  R. H. Sohn,et al.  Redox changes of cultured endothelial cells and actin dynamics. , 2000, Circulation research.

[11]  S. Schwarze,et al.  In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. , 2000, Trends in pharmacological sciences.

[12]  R. Loire,et al.  Accelerated coronary atherosclerosis and arteriosclerosis in young human‐immunodeficiency‐virus‐positive patients , 2000, Coronary artery disease.

[13]  M. Giacca,et al.  Identification of Specific Molecular Structures of Human Immunodeficiency Virus Type 1 Tat Relevant for Its Biological Effects on Vascular Endothelial Cells , 2000, Journal of Virology.

[14]  Tetsuro Ago,et al.  Mechanism for Phosphorylation-induced Activation of the Phagocyte NADPH Oxidase Protein p47 phox , 1999, The Journal of Biological Chemistry.

[15]  G. Barillari,et al.  The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. , 1999, Blood.

[16]  R. Stauber,et al.  Intracellular trafficking and interactions of the HIV-1 Tat protein. , 1998, Virology.

[17]  J. Frost,et al.  Differential Effects of PAK1-activating Mutations Reveal Activity-dependent and -independent Effects on Cytoskeletal Regulation* , 1998, The Journal of Biological Chemistry.

[18]  E. Levin,et al.  Extracellular Signal-regulated Protein Kinase/Jun Kinase Cross-talk Underlies Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation* , 1998, The Journal of Biological Chemistry.

[19]  J. Lambeth,et al.  Regulation of the Neutrophil Respiratory Burst Oxidase , 1998, The Journal of Biological Chemistry.

[20]  Zhong-ying Liu,et al.  Human Immunodeficiency Virus Tat Modulates the Flk-1/KDR Receptor, Mitogen-Activated Protein Kinases, and Components of Focal Adhesion in Kaposi’s Sarcoma Cells , 1998, Journal of Virology.

[21]  L. Lim,et al.  A Conserved Negative Regulatory Region in αPAK: Inhibition of PAK Kinases Reveals Their Morphological Roles Downstream of Cdc42 and Rac1 , 1998, Molecular and Cellular Biology.

[22]  J. A. Badwey,et al.  Cofilin undergoes rapid dephosphorylation in stimulated neutrophils and translocates to ruffled membranes enriched in products of the NADPH oxidase complex. Evidence for a novel cycle of phosphorylation and dephosphorylation , 1997, Histochemistry and Cell Biology.

[23]  X. Q. Chen,et al.  Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes , 1997, Molecular and cellular biology.

[24]  R. Soldi,et al.  The angiogenesis induced by HIV–1 Tat protein is mediated by the Flk–1/KDR receptor on vascular endothelial cells , 1996, Nature Medicine.

[25]  U. Löhrs,et al.  Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. , 1996, The American journal of pathology.

[26]  G. Fontanini,et al.  Promotion of tumour metastases and induction of angiogenesis by native HIV‐1 Tat protein from BK virus/tat transgenic mice , 1996, AIDS.

[27]  P. Krammer,et al.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.

[28]  A. Albini,et al.  Angiogenic properties of human immunodeficiency virus type 1 Tat protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. K. Reynolds,et al.  The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice , 1988, Nature.

[30]  N. S. Mcnutt,et al.  Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. , 1983, The American journal of pathology.

[31]  F. Nwariaku,et al.  TNFα Activates c-Jun Amino Terminal Kinase through p47phox , 2002 .

[32]  J. Lambeth,et al.  Regulation of the Neutrophil Respiratory Burst Oxidase IDENTIFICATION OF AN ACTIVATION DOMAIN IN p67 phox * generation by neutrophil , 1998 .